Miriam Kolko
@KolkoMiriam
Followers
93
Following
99
Media
2
Statuses
22
Professor i Translational Eye Research | Overlæge i øjensygdomme på Rigshospitalet | Grøn stær specialist | Leder af forskningsgruppen EyeTRU
Joined June 2012
Are you interested in image analysis using deep learning? Then take a look at this position as a PhD fellow in a joint project between @KolkoEye and @DTU_VisualComp. https://t.co/iBaWcoxlui
#EyeTRU #projectFOREVER #visualcomputing #dtucompute @KolkoMiriam @BjorholmDahl
linkedin.com
OPEN POSITION: PhD fellowship in image analysis using deep learning at Department of Drug Design and Pharmacology. We are seeking a highly motivated PhD student to work on this joint project between...
0
2
4
👩🎓Congratulations to @VohraRupali from #eyetru who has finalized her BRIDGE - Translational Excellence Program post-doc fellowship!! 🎉🥳 Keep up the excellent work!
0
1
8
@TheBrunakLab is part of the FOREVER project to identify early signs of eye diseases before they develop in the patient. Exciting collaboration with @KolkoEye and Synoptik A/S. https://t.co/tJN8Meibog
cpr.ku.dk
Researchers from the University of Copenhagen receives a grant to launch a project to identify early signs of eye diseases before they develop in the patient.
1
3
3
🎉We are pleased to announce that our great FOREVER project was finally launched! 🙌🏽🎊 The recruitment of participants has now started in Synoptik stores in Denmark. You can read more about FOREVER here 👇🏼 https://t.co/QAZS8zhkFY
0
2
9
Grøn stær truer mange menneskers syn og bliver ofte opdaget for sent. Men med en bevilling på 14 mio. kr. fra Synoptik-Fonden skal professor @KolkoMiriam udvikle metoder til at opdage grøn stær, før sygdommen rammer. https://t.co/UpJAdwjflv
#dkforsk #sundpol #grønstær
0
2
10
You can find us also on LinkedIn! 🕵🏻 Go follow us for news and updates! 🙌🏽😊 https://t.co/fwGDYQBWw6
linkedin.com
Eye Translational Research Unit - Kolko group | 1,189 followers on LinkedIn. Research in Glaucoma. | Eye translational research
0
2
2
👩🏼🏫Together with author Knud Romer, @KolkoMiriam was invited to "Aftenshowet" to talk about glaucoma and the importance of timely diagnosis of this asymptomatic condition. You can watch the interview at the following link (min 41.45): https://t.co/RZwxu5gCKm
0
1
4
We are very pleased to announce that @KolkoEye has received a grant from the A.P. Møller Fonden to support research in glaucoma risk factors. Thank you for the recognition, we hope to raise awareness of the early detection of glaucoma. We can't wait to start the project!😁🙌🏽
0
2
11
Master's student @ZaynabMouhammad and co-authors from the @EyeTRU have published a review on the protective effects of GLP-1 receptor agonists and their potential future use in the treatment of glaucoma. You can read more here 🧐: https://t.co/qUGzrvnh8L
pmc.ncbi.nlm.nih.gov
Glaucoma is a common ocular neurodegenerative disease characterized by the progressive loss of retinal ganglion cells and their axons. It is the most common cause of irreversible blindness. With an...
0
4
8
🗣️ @EyeTRU Group leader @KolkoMiriam has given an interview about her research career and opinion on Open Science to @PLOSONE to celebrate the 15 years anniversary of the journal.🤩 You can read it in full here:
everyone.plos.org
This month marks 15 years since PLOS ONE published its first papers. As we celebrate this milestone, we invited authors of some of the first papers to be published, as well as an author of a more...
0
1
3
The magazine Øjenforeningen has published an interview with author Knud Romer. Here he talks about his journey with glaucoma, his encounter with @KolkoMiriam, and the importance of glaucoma awareness. Read the full interview. https://t.co/lLl41rkzH9
0
1
6
EyeTRU group leader @KolkoMiriam has been awarded a research grant for the project "Retinal organoids to study disease progression and intervention in glaucoma". It is included in The Glaucoma Foundation's 2020 Annual Report. Read about it on page 13 😁 https://t.co/7ZHh1ic2Oq
0
1
5
Hamid Ahmadi, Steffen Hamann, and @MiriamKolko have published a new article on the importance of using enhanced depth imaging OCT (EDI-OCT) to improve diagnosis in glaucoma-related optic nerve head damage. You can read more here: https://t.co/JYf7W6o7Wf
pubmed.ncbi.nlm.nih.gov
An 83-year-old woman with a long history of glaucoma and optic disc drusen (ODD) was referred for neuro-ophthalmological second opinion. The patient had been treated for decades with bilateral...
0
6
11
🗣️ #EyeTRU leader @KolkoMiriam will be giving a talk on "Clinical trials in glaucoma - is neuroprotection a reality?" at the annual conference on Advances in Glaucoma Research and Clinical Science (#AGRCS2021). You can follow it online on Sep 18 from 14:30-14:50 👁️👩💻
0
1
7
Today we had an inspiring joint meeting with Professor Verena Prokosch, from the University of Cologne, and her group. We set a plan for several interesting collaborations and, at @EyeTRU, we are simply looking forward to start working hand in hand with them.💡📝👩🔬
0
2
3
Tough times call for inventive solutions. We are very happy at EyeTRU with our new 360 camera, which will help us to carry our semi-presential group meetings even better from now on. 📹🔬🙌
0
2
9
Fantastisk forskningsseminar med EyeTRU. Tak til værterne og oplægsholdere. #dkforsk #Ophthalmology #synet #glaucoma
0
0
2
https://t.co/0sodjLPa2T Øjenforeningen var tydelig på folkemødet, hvor kampen mod blindhed fik fin opmærksomhed #synet #ophthalmology #Glaucoma #dkforsk
0
0
0
Fin artikel om udfordringerne på øjenområdet - det kræver flere debatter og mere fokus #fm2019 #synet #sundpol #dkforsk #ophthalmology
ojenforeningen.dk
Øjenforeningen advarer om, at patienter risikerer at blive blinde, mens de, billedligt talt, sidder i venteværelset:
0
0
0